Estados financieros detallados de iBio, Inc. (IBIO): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
iBio, Inc. registró ingresos de $100000 en el último ejercicio fiscal, con un CAGR de 5 años del -46.9%.
Márgenes de los últimos 12 meses: margen bruto 100.0%, margen operativo -351.4%, margen neto -330.4%.
Al precio actual de $1.18, IBIO presenta beneficios negativos (P/E no significativo) y un ROE del -38.55%. La capitalización bursátil es de $19M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Ingresos | $394000 | $444000 | $2.0M | $1.6M | $2.4M | $1.9M | 0 | $225000 | $400000 | $100000 |
| Coste de Ventas | 0 | 0 | 0 | $703000 | $1.5M | $3.8M | 0 | 0 | 0 | 0 |
| Beneficio Bruto | $394000 | $444000 | $2.0M | $935000 | $909000 | -$1.9M | 0 | $225000 | $400000 | $100000 |
| I+D | $4.1M | $4.0M | $5.5M | $3.6M | $10.0M | $9.8M | $10.3M | $5.2M | $8.3M | $19.6M |
| Generales y Administrativos | $10.6M | $10.7M | $12.3M | $11.4M | $21.9M | $18.0M | $18.5M | $11.7M | $10.7M | $10.6M |
| Gastos Operativos | $14.7M | $14.7M | $17.8M | $14.9M | $32.0M | $27.8M | $29.3M | $16.9M | $19.0M | $35.2M |
| Beneficio Operativo | -$14.3M | -$14.2M | -$15.8M | -$14.0M | -$31.1M | -$29.7M | -$29.3M | -$16.6M | -$18.6M | -$35.1M |
| EBITDA | -$12.5M | -$12.5M | -$13.9M | -$11.7M | -$28.6M | -$25.7M | -$27.8M | -$14.0M | -$17.0M | -$32.3M |
| Gastos por Intereses | $1.9M | $1.9M | $1.9M | $2.5M | $2.5M | $1.4M | $83000 | $172000 | $212000 | $53000 |
| Beneficio Antes de Impuestos | -$14.5M | -$16.1M | -$17.6M | -$16.4M | -$23.2M | -$29.5M | -$29.3M | -$15.4M | -$18.4M | -$33.0M |
| Impuestos | $347000 | $34000 | -$4000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$14.5M | -$16.1M | -$17.6M | -$16.4M | -$23.2M | -$50.4M | -$65.0M | -$24.9M | -$18.4M | -$33.0M |
| BPA | $-800.00 | $-770.00 | $-471.65 | $-304.64 | $-59.98 | $-2889.06 | $-106.18 | $-6.50 | $-1.75 | $-0.32 |
| BPA Diluido | $-800.00 | $-770.00 | $-471.65 | $-304.64 | $-59.98 | $-2889.06 | $-106.18 | $-6.50 | $-1.75 | $-0.32 |
| Acciones en Circulación (Diluidas) | $17822 | $21262 | $37852 | $125590 | $391240 | $17442 | $612250 | $3.8M | $10.5M | $104.1M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $100000 | 0 | 0 | 0 |
| Beneficio Bruto | -$189000 | -$241000 | -$250000 | $780000 |
| Beneficio Operativo | -$6.0M | -$6.9M | -$5.9M | -$16.4M |
| EBITDA | -$5.4M | -$8.7M | -$7.5M | -$10.8M |
| Beneficio Neto | -$5.7M | -$9.0M | -$7.7M | -$10.6M |
| BPA | $-0.11 | $-0.09 | $-0.06 | $-0.06 |
| BPA Diluido | $-0.11 | $-0.09 | $-0.06 | $-0.06 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Caja y Equivalentes | $8.1M | $15.9M | $4.4M | $55.1M | $77.4M | $22.7M | $7.3M | $14.2M | $8.6M | $56.4M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $19.6M | $10.8M | 0 | 0 | 0 | $31.6M |
| Cuentas por Cobrar | $175000 | $75000 | $97000 | $5.6M | $5.5M | $6.1M | $204000 | $713000 | $105000 | $1.1M |
| Inventario | $26000 | 0 | 0 | $798000 | $27000 | $3.9M | 0 | 0 | 0 | 0 |
| Activos Corrientes | $8.6M | $16.3M | $4.8M | $61.7M | $104.6M | $45.1M | $26.3M | $15.7M | $9.7M | $92.2M |
| Inmovilizado Material | $25.6M | $25.2M | $24.4M | $31.3M | $34.7M | $41.8M | $7.6M | $6.4M | $5.3M | $4.8M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $1.8M | $1.6M | $1.4M | $1.1M | $952000 | $4.9M | $5.4M | $5.4M | $6.8M | $1.8M |
| Activos Totales | $36.0M | $43.1M | $30.6M | $94.2M | $147.0M | $99.4M | $41.2M | $28.7M | $23.2M | $99.1M |
| Cuentas por Pagar | $332000 | $790000 | $1.0M | $1.8M | $2.3M | $4.3M | $1.8M | $358000 | $2.2M | $4.4M |
| Deuda a Corto | 0 | 0 | 0 | $261000 | $600000 | $22.2M | $13.6M | $218000 | $766000 | 0 |
| Pasivos Corrientes | $2.0M | $2.0M | $3.5M | $5.2M | $6.6M | $30.4M | $21.6M | $3.8M | $6.1M | $11.7M |
| Deuda a Largo | 0 | 0 | 0 | $339000 | 0 | 0 | 0 | $766000 | 0 | 0 |
| Pasivos Totales | $27.1M | $26.9M | $28.1M | $37.6M | $38.4M | $35.9M | $25.8M | $7.4M | $8.3M | $13.4M |
| Reservas | -$72.1M | -$88.2M | -$105.8M | -$150.4M | -$173.6M | -$223.9M | -$288.9M | -$313.8M | -$332.2M | -$365.3M |
| Patrimonio Neto | $8.9M | $16.2M | $2.5M | $56.6M | $108.6M | $63.5M | $15.4M | $21.3M | $14.9M | $85.7M |
| Deuda Total | $25.3M | $25.1M | $24.9M | $32.9M | $32.7M | $25.8M | $17.1M | $4.5M | $3.5M | $2.2M |
| Deuda Neta | $17.2M | $9.1M | $20.5M | -$22.2M | -$64.3M | -$7.8M | $9.7M | -$9.8M | -$5.1M | -$85.8M |
| Capital Circulante | $6.6M | $14.2M | $1.4M | $56.5M | $98.0M | $14.6M | $4.7M | $11.8M | $3.6M | $80.5M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $28.1M | $28.7M | $47.6M | $56.4M |
| Activos Totales | $64.2M | $64.4M | $85.8M | $99.1M |
| Pasivos Totales | $8.1M | $7.8M | $8.3M | $13.4M |
| Patrimonio Neto | $56.0M | $56.6M | $77.5M | $85.7M |
| Deuda Total | $3.3M | $2.5M | $2.3M | $2.2M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Beneficio Neto | -$16.1M | -$16.1M | -$17.6M | -$16.4M | -$23.2M | -$29.5M | -$65.0M | -$24.9M | -$18.4M | -$33.0M |
| Amortizaciones | $1.7M | $1.7M | $1.7M | $2.2M | $2.4M | $3.8M | $1.4M | $1.2M | $291000 | $88000 |
| Compensación en Acciones | $1.0M | $770000 | $241000 | $388000 | $1.6M | $4.4M | $4.4M | $2.0M | $1.5M | $1.4M |
| Cambio en Capital Circulante | $290000 | $88000 | $1.5M | $470000 | -$11.2M | $3.2M | $5.9M | -$3.2M | $479000 | $2.5M |
| Flujo de Caja Operativo | -$13.2M | -$13.5M | -$14.0M | -$13.3M | -$30.1M | -$37.8M | -$30.4M | -$18.6M | -$15.3M | -$23.2M |
| Inversiones (CapEx) | -$1.6M | -$1.1M | -$990000 | -$1.2M | -$5.2M | -$7.3M | -$5.7M | -$210000 | -$16000 | -$578000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | -$692000 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | -$39000 | -$7000 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$14.8M | -$14.6M | -$15.0M | -$14.5M | -$35.2M | -$45.1M | -$36.2M | -$18.8M | -$15.3M | -$23.8M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$5.7M | -$5.2M | -$6.1M | -$6.2M |
| Inversiones (CapEx) | -$32000 | -$516000 | -$11000 | -$19000 |
| Flujo de Caja Libre | -$5.7M | -$5.8M | -$6.1M | -$6.2M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $323000 | $253000 | $377000 | $420000 |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Crecimiento Ingresos (anual) | | +12.7% | +354.5% | -18.8% | +44.7% | -20.5% | -100.0% | | +77.8% | -75.0% |
| Crecimiento Beneficio Neto (anual) | | -10.8% | -9.2% | +6.6% | -41.2% | -117.1% | -29.0% | +61.7% | +26.2% | -79.8% |
| Crecimiento BPA (anual) | | +3.8% | +38.7% | +35.4% | +80.3% | -4716.7% | +96.3% | +93.9% | +73.1% | +81.7% |
| Cambio en Acciones (anual) | | +19.3% | +78.0% | +231.8% | +211.5% | -95.5% | +3410.2% | +525.7% | +174.1% | +891.1% |
| Crecimiento FCF (anual) | | +1.3% | -2.8% | +3.1% | -143.0% | -28.1% | +19.8% | +48.1% | +18.4% | -55.3% |
| Margen Bruto | 100.0% | 100.0% | 100.0% | 57.1% | 38.3% | -101.2% | | 100.0% | 100.0% | 100.0% |
| Margen Operativo | -3622.8% | -3204.3% | -782.4% | -854.9% | -1312.1% | -1576.3% | | -7392.9% | -4650.5% | -35141.0% |
| Margen EBITDA | -3181.2% | -2811.7% | -691.2% | -716.5% | -1204.3% | -1365.3% | | -6231.6% | -4259.8% | -32345.0% |
| Margen Neto | -3688.3% | -3627.3% | -871.8% | -1003.6% | -978.8% | -2674.7% | | -11069.8% | -4594.2% | -33044.0% |
| Margen FCF | -3745.2% | -3279.1% | -741.6% | -885.2% | -1485.7% | -2395.5% | | -8339.6% | -3830.0% | -23796.0% |
| Tasa Impositiva Efectiva | -2.4% | -0.2% | 0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| FCF por Acción | $-827.97 | $-684.74 | $-395.36 | $-115.45 | $-90.04 | $-2587.55 | $-59.08 | $-4.90 | $-1.46 | $-0.23 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $17822 | $21262 | $37852 | $125590 | $391240 | $17442 | $612250 | $3.8M | $10.5M | $104.1M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -38.55% |
| Rentabilidad sobre capital invertido | -39.97% |
| Rentabilidad sobre activos | -33.34% |
| Margen bruto | 100.00% |
| Margen operativo | -35141.00% |
| Margen neto | -33044.00% |
Salud financiera
| Deuda / Patrimonio | 0.03 |
| Ratio corriente | 7.85 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -21.93 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| P/E | -2.44 | -0.58 | -0.74 | -3.64 | -12.59 | -0.04 | -0.11 | -0.31 | -0.44 | -5.47 |
| P/VC | 3.90 | 0.59 | 5.38 | 2.46 | 2.72 | 0.04 | 0.49 | 0.36 | 0.54 | 2.12 |
| P/V | 88.21 | 21.55 | 6.57 | 85.11 | 124.58 | 1.20 | 0.00 | 34.22 | 20.03 | 1821.05 |
| Margen Bruto | 100.0% | 100.0% | 100.0% | 57.1% | 38.3% | -101.2% | 0.0% | 100.0% | 100.0% | 100.0% |
| Margen Operativo | -3622.8% | -3204.3% | -782.4% | -854.9% | -1312.1% | -1576.3% | 0.0% | -7392.9% | -4650.5% | -35141.0% |
| Margen Neto | -3688.3% | -3627.3% | -871.8% | -1003.6% | -978.8% | -2674.7% | 0.0% | -11069.8% | -4594.2% | -33044.0% |